MSD in talks with Medicines Patent Pool for additional licenses for molnupiravir

  • by
MSD entered into a voluntary licensing agreement with five Indian drug makers including Sun Pharma, Cipla, Dr. Reddy’s, Emcure and Hetero for molnupiravir, an experimental drug that is currently tested to treat Covid-19 infections. Merck is running the clinical trials for molnupiravir with its partner Ridgeback Biotherapeutics.